Beneficial effect of the calcium-sensitizing drug EMD 57033 in a canine model of dilated heart failure

Clinical Science

Volumn 93, Issue 3, 1997, Pages 213-218

  Drake Holland, Angela J ^a   Lee, John A ^b   Hynd, John ^a   Clarke, Sinéad B ^a   Noble, Mark I M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Calcium sensitizing drugs; Canine model; EMD 57033; Heart failure

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; CALCIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DOG; DRUG EFFECT; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PACING; HEART RATE; HEART RIGHT VENTRICLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; INOTROPISM; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR RESISTANCE;

EID: 0030885706     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930213     Document Type: Article

References (32)

1. Schocken DD, Arrieta MI, Leaverton PE. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-6.
2. Kannel WB, Ho K, Thorn T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72(Suppl.): S3-S9.
3. Ehrsam RE, Perruchoud A, Burkart F, et al. Influence of age on pulmonary hemodynamics at rest and during supine exercise. Clin Sci 1983; 65: 653-60.
4. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990; 50: 137-43.
5. 2+) during inotropic interventions in isolated rat myocytes. J Physiol 1991; 437: 351-7.
6. Levi AJ, Boyett MR, Lee CO. The cellular action of digitalis glycosides on the heart. Prog Biophys Mol Biol 1994; 62: 1-54.
7. Lakatta EG, Guarnieri T. Spontaneous myocardial calcium oscillations: are they linked to ventricular fibrillation? J Cardiovasc Electrophysiol 1993; 4: 473-89.
8. 2+ release leads to heterogeneity of contractile and electrical properties of the heart. Basic Res Cardiol 1992; 87: 93-104.
9. Clusin WT. Role of calcium activated ion currents in the heart. In: Speralakis E, ed. Physiology and pathophysiology of the heart. Lancaster: Kluwer Academic Publishers, 1988: 95-114.
10. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325: 1468-75.
11. Lee JA, Allen DG. EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle. Circ Res 1991; 69: 927-36.
12. Lee JA, Allen DG. Modulation of cardiac calcium sensitivity in a new approach to increasing the strength of the heart. Oxford: Oxford University Press, 1993: 1-347.
13. Lues I, Beier N, Jonas R, Klockow M, Haeusler G. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J Cardiovasc Pharmacol 1993; 21: 883-92.
14. Solaro RJ, Gambassi G, Warshaw DM, et al. Stereospecific actions of thiadiones on canine cardiac myocytes and myofilaments. Circ Res 1993; 73: 981-90.
15. 2+ in isolated ferret cardiac muscle. Circ Res 1993; 73: 61-70.
16. Jonas R, Klocknow M, Lues I. Preparation of the enantiomers of the novel Ca-sensitizer EMD 53998. Bioorg Med Chem Lett 1993; 2: 589-92.
17. Armstrong PW, Stopps TP, Ford SE, de Bold AJ. Rapid ventricular pacing in the dog: pathological studies of heart failure. Circulation 1986; 74: 1075-84.
18. Travill CM, Williams TDM, Pate P, et al. Haemodynamic and neurohumoral response in heart failure produced by rapid atrial ventricular pacing. Cardiovasc Res 1992; 26: 783-90.
19. 2+ transient in rat myocardium. J Mol Cell Cardiol 1991; 23: 325-31.
20. Gross T, Lues I, Daut J. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle. J Mol Cell Cardiol 1993; 25: 239-44.
21. Lee JA, Shah N, White J, Orchard CH. A novel thiadiazone derivative fully reverses acidosis-induced depression of force in cardiac muscle by a calcium sensitising effect. Clin Sci 1993; 84: 141-4.
22. Than N, Shah N, White J, Lee JA, Orchard CH. Effects of acidosis and hypoxia on the response of isloted ferret cardiac muscle to inotropic agents. Cardiovasc Res 1994; 28: 1209-17.
23. Evans SJ, Levi AJ, Lee JA, Jones JV. EMD 57033 enhances arrhythmias associated with increase wall-stress in the working rat heart. Clin Sci 1995; 89: 59-67.
24. Schelling P, Becker KH, Lues I, et al. In vivo characterisation of the cardiotonic action of EM57033, a novel drug that increases left ventricular contractility via sensitisation of the myofibrils to calcium. J Mol Cell Cardiol 1991; 23(Suppl V): S69.
25. Cleland JGF. Ancillary diagnostic and therapeutic issues. Curr Opin Cardiol 1992; 7: 408-15.
26. Gheorghiade M, Sueta CA, Adams KF, et al. Multicenter randomised trial of epoprostenol in patients with severe heart failure. J Am Coll Cardiol 1992; 19: 216A.
27. Cleland JGF, Oakley CM. Vascular tone in heart failure: the neuroendocrine-therapeutic interface. Br Heart J 1991; 66: 264-47.
28. Cleland JGF, Dutka DP. Optimizing heart failure pharmacotherapy: the ideal combination. Br Heart J 1994; 72 (Suppl.): S73-9.
29. Lee JA, Allen DG. Calcium sensitizers and heart failure. Expert Opin Invest Drugs 1995; 4: 1057-65.
30. The PICO Investigators. Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) Trial. Heart 1996; 76: 233-41.
31. Noble MIM, Milne ENC, Goerke RJ, et al. Left ventricular filling and diastolic pressure-volume relations in the conscious dog. Circ Res 1969; 24: 269-83.
32. Teramura S, Yamakado T, Maeda M, Nakano T. Effects of MCI-154, a calcium sensitiser, on left ventricular systolic and diastolic function in pacing-induced heart failure in the dog. Circulation 1997; 95: 732-9.